omeprazole
InChIKey: SUBDBMMJDZJVOS-UHFFFAOYSA-N
Need public description.
Compound information managed by NaPDI
None listed
None listed
None listed
ID | Subject of Study | Study Name | Name | Type | Overall Effect | Enzymes | Transporters | Object | Object Metabolite | Precipitant |
---|---|---|---|---|---|---|---|---|---|---|
NPDI-nzhlHQ | Goldenseal (Hydrastis canadensis) | Repeated administration of berberine inhibits cytochromes P450 in humans | CYP2C19 Experiment | In Vivo Interaction | negative — No Effect (based on bioequivalence limits) |
|
|
omeprazole | berberine | |
NPDI-fw_WMw | Cannabis (Cannabis sativa) | Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. | Inhibition of CYP2C19 by Cannabidiol | In Vitro Enzyme Inhibition | positive — In Vitro Enzyme Inhibition |
|
|
omeprazole | 5-hydroxyomeprazole | cannabidiol |
NPDI-jJ11Ig | Cannabis (Cannabis sativa) | Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes | 6-alpha-OH-CBD-omeprazole | In Vitro Enzyme Inhibition | positive — In Vitro Enzyme Inhibition |
|
|
cannabidiol | 6α-oh-cannabidiol | omeprazole |
Compound information from external resources
Resource | Identifier |
---|---|
Google search | SUBDBMMJDZJVOS-UHFFFAOYSA-N |